Context: In Burkina Faso, there is only one retinoblastoma treatment center located in the capital. Nowadays, the treatment of retinoblastoma has benefited from the contribution of scientific progress. Objective: The aim was to take stock of the situation of retinoblastoma in the pediatric oncology department from January 1, 2010 to December 31, 2019. Materials and Methods: This was a descriptive cross-sectional study with retrospective data collection over a 10-year period, based on records of patients admitted to pediatric oncology department of CHU-YO. Data were analysed using CS Pro version 7.2 software. Categorical variables were compared using Pearson’s Chi-square test at the 5% significance level. Overall survival was estimated using the Kaplan-Meier method. Operational definitions were used for lost to follow-up, consultation and diagnosis delays. Results: We collected a total of 204 cases in 10 years, i.e. an annual average of 20.4 cases/year. The mean age at diagnosis was 37.5 months for unilateral cases and 26.4 months for bilateral cases. Male predominance was noted, with a sex ratio of 1.31. The majority of patients came from disadvantaged backgrounds (72% farming fathers and 91% housewives). Clinically, leukocoria and exophthalmos were the main presenting features. The average time to consultation was long (8.73 months) and unilateral localization was predominantly unilateral at 77%. In terms of treatment, 102 patients were eligible for curative treatment and 80 for palliative treatment. The prognosis was poor, with 41% death and numerous cases of lost to follow-up (18%). Overall survival was estimated at 32%. The factor associated with the lethality of retiniblastoma was the extension of the tumor to other organs. Conclusion: Recognition of the early clinical signs of retinoblastoma can anticipate the occurrence of this cancer. Health professionals should be encouraged to perform the Buckner test every time they come into contact with children aged 0 to 5, and the public should be encouraged to examine their children’s eyes.
References
[1]
Goumbri, O.M., Domagni, O.E., Sanou, A.M., Konsegre, V. and Soudre, R.B. (2009) Aspects épidémiologiques et histopathologiques des cancers au Burkina Faso. Journal Africain du Cancer/African Journal of Cancer, 4, 207-211. https://doi.org/10.1007/s12558-009-0052-x
[2]
Aerts, I., Lumbroso-Le Rouic, L., Gauthier-Villars, M., Brisse, H., Doz, F. and Desjardins, L. (2006) Retinoblastoma. Orphanet Journal of Rare Diseases, 1, Article No. 31. https://doi.org/10.1186/1750-1172-1-31
[3]
Kivelä, T. (2009) The Epidemiological Challenge of the Most Frequent Eye Cancer: Retinoblastoma, an Issue of Birth and Death. British Journal of Ophthalmology, 93, 1129-1131. https://doi.org/10.1136/bjo.2008.150292
[4]
Chintagumpala, M., Chevez-Barrios, P., Paysse, E.A., Plon, S.E. and Hurwitz, R. (2007) Retinoblastoma: Review of Current Management. The Oncologist, 12, 1237-1246. https://doi.org/10.1634/theoncologist.12-10-1237
[5]
Ali, A.A., Elsheikh, S.M., Elhaj, A., Osman, N., Abuidris, D., Eltayeb, E.A., Qaddoumi, I., et al. (2011) Clinical Presentation and Outcome of Retinoblastoma among Children Treated at the National Cancer Institute (NCI) in Gezira, Sudan: A Single Institution Experience. Ophthalmic Genetics, 32, 122-125. https://doi.org/10.3109/13816810.2010.546822
[6]
Togo, B., Traoré, F., Togo, A.P., Togo, P., Diakité, A.A. and Traoré, B. (2014) Épidémiologie et pronostic des cancers pédiatriques au CHU Gabriel-Touré de Bamako. Médecine et Santé Tropicales, 24, 68-72. https://doi.org/10.1684/mst.2014.0291
[7]
Jehanne, M., Brisse, H., Gauthier-Villars, M., Lumbroso-le Rouic, L., Freneaux, P. and Aerts, I. (2014) Le rétinoblastome: Les avancées récentes. Bulletin du Cancer, 101, 380-387. https://doi.org/10.1684/bdc.2014.1931
[8]
Ancona-Lezama, D., Dalvin, L.A. and Shields, C.L. (2020) Modern Treatment of Retinoblastoma: A 2020 Review. Indian Journal of Ophthalmology, 68, 2356-2365. https://doi.org/10.4103/ijo.IJO_721_20
[9]
Sankara, P., Djiguimde, W.P., Ahnoux-Zabsonre, A., Sanou, J., Meda-Hien, G., Diomande, I.A., Sidibe, G., et al. (2020) Caractéristiques épidémio-cliniques du rétinoblastome au Centre Hospitalier Universitaire Yalgado Ouedraogo du Burkina Faso: À propos de 32 cas. Pan African Medical Journal, 37, Article 269. https://doi.org/10.11604/pamj.2020.37.269.20556
[10]
Fabian, I.D., Abdallah, E., Abdullahi, S.U., Abdulqader, R.A., Boubacar, S.A., Ademola-Popoola, D.S., Gole, G.A., et al. (2020) Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncology, 6, 685-695. https://doi.org/10.1001/jamaoncol.2019.6716
[11]
Mallon, B., Kaboré, R., Couitchere, L., Akonde, F.B., Lukamba, R., Dackono, T.A., Patte, C., et al. (2022) The Development of an International Childhood Cancer Hospital Register Database in 13 African Countries. A Project of the French African Pediatric Oncology Group (GFAOP). Pediatric Blood & Cancer, 69, e29464. https://doi.org/10.1002/pbc.29464
[12]
Ribeiro, R.C. and Pui, C.H. (2005) Saving the Children—Improving Childhood Cancer Treatment in Developing Countries. The New England Journal of Medicine, 352, 2158-2160. https://doi.org/10.1056/NEJMp048313
[13]
Shields, C.L., Shields, J.A. and Shah, P. (1991) Retinoblastoma in Older Children. Ophthalmology, 98, 395-399. https://doi.org/10.1016/S0161-6420(91)32283-8
[14]
Karcioglu, Z.A., Gordon, R.A. and Karcioglu, G.L. (1985) Tumor Seeding in Ocular Fine Needle Aspiration Biopsy. Ophthalmology, 92, 1763-1767. https://doi.org/10.1016/S0161-6420(85)34105-2
[15]
Traore, F., Togo, B., Sylla, F., Cheick, T.B., Diakité, A.A., Dicko-Traore, F., Desjardins, L., et al. (2013) Le rétinoblastome: Ètat des lieux au Mali et programme d’aide au diagnostic précoce, aux traitements et à la réhabilitation. Bulletin du Cancer, 100, 161-165. https://doi.org/10.1684/bdc.2013.1703
[16]
Dial, C., Doh, K., Thiam, I., Roth, P.A.N., Moreira, C. and Woto-Gaye, G. (2019) Retinoblastoma in Children: A Case Series from Senegal. Oxford Medical Case Reports, 2019, omz084. https://doi.org/10.1093/omcr/omz084
[17]
Santos, D.D. (2015) Etude de cout sur la prise en charge du retinoblastome au mali. Allinace Mondiale Contre le Cancer. https://s5033a508347127d4.jimcontent.com/download/version/1580278951/module/6111991366/name/etude-de-cout-retinoblastome-amcc.pdf
[18]
Sherief, S.T., Mulatu, D.G., Wu, F., O’Banion, J. and Dimaras, H. (2022) Clinicopathological Presentation of Retinoblastoma in Ethiopia. Ocular Oncology and Pathology, 8, 168-174. https://doi.org/10.1159/000525113
[19]
ÖZkan, A., Pazarli, H., Celkan, T., Karaman, S., Apak, H., Kaner, G., Yildiz, I., et al. (2006) Retinoblastoma in Turkey: Survival and Clinical Characteristics 1981-2004. Pediatrics International, 48, 369-373. https://doi.org/10.1111/j.1442-200X.2006.02223.x
[20]
Vahedi, A., Lumbroso-Le Rouic, L., Gabriel, C.L., Doz, F., Aerts, I., Brisse, H., Desjardins, L., et al. (2008) Diagnostic différentiel du rétinoblastome: Ètude rétrospective de 486 cas. Journal Français d’Ophtalmologie, 31, 165-172. https://doi.org/10.1016/S0181-5512(08)70349-8
[21]
Broaddus, E., Topham, A. and Singh, A.D. (2009) Incidence of Retinoblastoma in the USA: 1975-2004. British Journal of Ophthalmology, 93, 21-23. https://doi.org/10.1136/bjo.2008.138750
[22]
Zhao, J., Li, S., Shi, J. and Wang, N. (2011) Clinical Presentation and Group Classification of Newly Diagnosed Intraocular Retinoblastoma in China. British Journal of Ophthalmology, 95, 1372-1375. https://doi.org/10.1136/bjo.2010.191130
[23]
Nummi, K. and Kivelä, T.T. (2021) Retinoblastoma in Finland, 1964-2014: Incidence and Survival. British Journal of Ophthalmology, 105, 63-69. https://doi.org/10.1136/bjophthalmol-2019-315744
[24]
Kagmeni, G., Nguefack, F. and Monebenimp, F. (2013) Le rétinoblastome dans la région de l’ouest Cameroun: Aspects cliniques, histologiques et thérapeutiques. Health Sciences and Disease, 14, 2.
[25]
MacCarthy, A., Draper, G.J., Steliarova-Foucher, E. and Kingston, J.E. (2006) Retinoblastoma Incidence and Survival in European Children (1978-1997) Report from the Automated Childhood Cancer Information System Project. European Journal of Cancer, 42, 2092-2102. https://doi.org/10.1016/j.ejca.2006.06.003
[26]
Chebbi, A., Bouguila, H., Boussaid, S., Aleya, N.B., Zgholi, H., Malek, I., Nacef, L., et al. (2014) Le profil clinique du rétinoblastome en Tunisie. Journal Français d’Ophtalmologie, 37, 442-448. https://doi.org/10.1016/j.jfo.2014.01.009
[27]
Sow, A.S., Roth, P.N., Moreira, C., Akonde, F.D., Ka, A.M., Sow, M.N., Ndiaye, M.R., et al. (2014) Thérapeutique du rétinoblastome: Expérience sénégalaise. Journal Français d’Ophtalmologie, 37, 381-387. https://doi.org/10.1016/j.jfo.2013.12.009
[28]
Ramírez-Ortiz, M.A., Ponce-Castañeda, M.V., Cabrera-Muñoz, M.L., Medina-Sansón, A., Liu, X. and Orjuela, M.A. (2014) Diagnostic Delay and Sociodemographic Predictors of Stage at Diagnosis and Mortality in Unilateral and Bilateral Retinoblastoma. Cancer Epidemiology, Biomarkers & Prevention, 23, 784-792. https://doi.org/10.1158/1055-9965.EPI-13-1069
[29]
Faranoush, M., Hedayati Asl, A.A., Mehrvar, A., Mehrvar, N., Zangooei, R., Abadi, E., Alebouyeh, M. and Tashvighi, M. (2014) Consequences of Delayed Diagnosis in Treatment of Retinoblastoma. Iranian Journal of Pediatrics, 24, 381-386.
[30]
Palazzi, M.A., Stephan, C., Brandalise, S.R. and Aguiar, S.D.S. (2013) Retinoblastoma Diagnosis: A Proposal Based on the Experience of Centro Infantile Boldrini, Brazil. Pediatric Hematology and Oncology, 30, 379-385. https://doi.org/10.3109/08880018.2013.775201
[31]
Butros, L.J., Abramson, D.H. and Dunkel, I.J. (2002) Delayed Diagnosis of Retinoblastoma: Analysis of Degree, Cause, and Potential Consequences. Pediatrics, 109, e45-e45. https://doi.org/10.1542/peds.109.3.e45
[32]
Dimaras, H., Kimani, K., Dimba, E.A., Gronsdahl, P., White, A., Chan, H.S., Gallie, B.L. (2012) Retinoblastoma. The Lancet, 379, 1436-1446. https://doi.org/10.1016/S0140-6736(11)61137-9
[33]
Selistre, S.G., Maestri, M.K., Santos-Silva, P., Schüler-Faccini, L., Guimarães, L.S., Giacomazzi, J., Ashton-Prolla, P., et al. (2016) Retinoblastoma in a Pediatric Oncology Reference Center in Southern Brazil. BMC Pediatrics, 16, Article No. 48. https://doi.org/10.1186/s12887-016-0579-9
[34]
Lin, P. and O’Brien, J.M. (2009) Frontiers in the Management of Retinoblastoma. American Journal of Ophthalmology, 148, 192-198. https://doi.org/10.1016/j.ajo.2009.04.004
[35]
Gallie, B. (2009) Canadian Guidelines for Retinoblastoma Care. Canadian Journal of Ophthalmology/Journal Canadiend’Ophtalmologie, 44, 639-642. https://doi.org/10.3129/i09-229
[36]
KakaHY, A., Sylla, F., Ali, M.H. and Amza, A. (2016) Les particularités du rétinoblastome au Niger. European Scientific Journal, 12, 84. https://doi.org/10.19044/esj.2016.v12n3p84
[37]
Wakamb, G.K.A., Nkashama, G.M., Mbuli, R.L.B., Borasisi, G.C. and Nikulu, J.I. (2013) Problématique de la prise en charge du cancer de l’enfant: Expérience du rétinoblastome à Lubumbashi (RD Congo) et importance du diagnostic précoce. Pan African Medical Journal, 14, Article 64. https://doi.org/10.11604/pamj.2013.14.64.2342
[38]
Lukamba, R.M., Yao, J.J.A., Kabesha, T.A., Budiongo, A.N., Monga, B.B., Mwembo, A.T., Stefan, C.D., et al. (2018) Retinoblastoma in Sub-Saharan Africa: Case Studies of the Republic of Côte d’Ivoire and the Democratic Republic of the Congo. Journal of Global Oncology, 4, 1-8. https://doi.org/10.1200/JGO.17.00056
[39]
Rodrigues, K.E., Latorre, M.D.R. and Camargo, B.D. (2004) Delayed Diagnosis in Retinoblastoma. Jornal de Pediatria, 80, 511-516. https://doi.org/10.2223/1266
[40]
Choi, S., Han, J.W., Kim, H., Kim, B.S., Kim, D.J., Lee, S.C. and Lyu, C.J. (2013) Combined Chemotherapy and Intra-Arterial Chemotherapy of Retinoblastoma. Korean Journal of Pediatrics, 56, 254-259. https://doi.org/10.3345/kjp.2013.56.6.254
[41]
Ndiaye, M.R., Ndoye, P.A., Ndiaye, C.S., Ba, E., Ndoye, N. and Wade, A. (1994) La chirurgie mutilante dans le rétinoblastome. Médecine d’Afrique Noire, 41, 367-369.
[42]
Gombos, D.S., Kelly, A., Coen, P.G., Kingston, J.E. and Hungerford, J.L. (2002) Retinoblastoma Treated with Primary Chemotherapy Alone: The Significance of Tumour Size, Location, and Age. British Journal of Ophthalmology, 86, 80-83. https://doi.org/10.1136/bjo.86.1.80
[43]
Kazadi Lukusa, A., Aloni, M.N., Kadima-Tshimanga, B., Mvitu-Muaka, M., Gini Ehungu, J.L., Ngiyulu, R., BudiongoNzazi, A., et al. (2012) Retinoblastoma in the Democratic Republic of Congo: 20 Year Review from a Tertiary Hospital in Kinshasa. Journal of Cancer Epidemiology, 2012, Article ID: 920468. https://doi.org/10.1155/2012/920468
[44]
Luo, C. and Deng, Y.P. (2013) Retinoblastoma: Concerning Its Initiation and Treatment. International Journal of Ophthalmology, 6, 397-401. https://doi.org/10.3980/j.issn.2222-3959.2013.03.26
[45]
Cruz-Gálvez, C.C., Ordaz-Favila, J.C., Villar-Calvo, V.M., Cancino-Marentes, M.E. and BoschCanto, V. (2022) Retinoblastoma: Review and New Insights. Frontiers in Oncology, 12, Article 963780. https://doi.org/10.3389/fonc.2022.963780
[46]
Essuman, V.A., Beyuo, V.M. and Dimaras, H. (2023) Retinoblastoma, the African Context. In: Chawla, B.V. and Aronow, M.E., Eds., Global Perspectives in Ocular Oncology, Springer, Cham, 379-384. https://doi.org/10.1007/978-3-031-08250-4_37
[47]
Francis, J.H., Roosipu, N., Levin, A.M., Brodie, S.E., Dunkel, I.J., Gobin, Y.P. and Abramson, D.H. (2018) Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy. Neoplasia, 20, 757-763. https://doi.org/10.1016/j.neo.2018.05.007
[48]
Kopelman, J.E., McLean, I.W. and Rosenberg, S.H. (1987) Multivariate Analysis of Risk Factors for Metastasis in Retinoblastoma Treated by Enucleation. Ophthalmology, 94, 371-377. https://doi.org/10.1016/S0161-6420(87)33436-0
[49]
Cuenca, A., Giron, F., Castro, D., Fandino, A., Guitter, M., de Dávila, M.T. and Chantada, G. (2009) Microscopic Scleral Invasion in Retinoblastoma: Clinicopathological Features and Outcome. Archives of Ophthalmology, 127, 1006-1010. https://doi.org/10.1001/archophthalmol.2009.174
